MOTS-c

Mitochondrial-encoded 16 amino acid peptide explored as an exercise-mimetic regulator of AMPK, metabolic fitness, stress resistance and healthy aging.

Evidence: Strong Preclinical + Emerging Human Function: Metabolic & Mitochondrial Fitness Class: Mitochondrial-derived peptide (MDP)

Explore calculators for this peptide

Use the Peptide Research Tools to experiment with reconstitution, mg/kg ranges and simplified exposure curves for MOTS-c, including “with vs without exercise” scenarios. All values are placeholders and must be aligned with your own research protocol.

Open MOTS-c in calculators →

Research frame & potential applications

MOTS‑c is a mitochondrial-encoded peptide that translocates to the nucleus during metabolic stress, activates AMPK and remodels gene expression toward enhanced mitochondrial biogenesis, glucose uptake and fatty-acid oxidation. It is being investigated as an exercise-mimetic signal for improving metabolic flexibility, endurance, cardiometabolic health and age-related resilience in preclinical and early human models.

Research areas & putative benefits

How MOTS‑c is deployed as a mitochondrial and exercise-signalling tool.

Improving insulin resistance, glucose tolerance and lipid handling in high-fat diet and metabolic syndrome models.
Enhancing skeletal muscle endurance, mitochondrial function and exercise capacity across age groups in animals.
Supporting cardiometabolic adaptation to training, including myocardial efficiency and stress resilience.
Exploring healthy-aging angles by linking mitochondrial-nuclear signalling to proteostasis, stress responses and physical function in older organisms.

Mechanism stack

Key pathways linking MOTS‑c, exercise signalling and mitochondrial health.

Origin & shuttling

Mitochondrial-encoded → nuclear signalling

MOTS‑c is encoded in mitochondrial DNA, produced in response to metabolic stress and can translocate to the nucleus, where it modulates transcription of stress-response and metabolic genes.

Energy sensing

AMPK activation

MOTS‑c activates AMPK and downstream PGC‑1α, promoting mitochondrial biogenesis, GLUT4 expression, fatty-acid oxidation and improved cellular energy balance in muscle and other tissues.

Metabolic reprogramming

Glucose & lipid utilisation

By enhancing mitochondrial function and fuel switching, MOTS‑c improves glucose uptake, attenuates insulin resistance and increases reliance on fat oxidation during exercise-like challenges in preclinical models.

Exercise synergy

Exercise-induced, exercise-amplifying

Endogenous MOTS‑c levels rise with endurance training, and exogenous MOTS‑c further augments exercise-induced adaptations, suggesting a feedback loop between training stress and mitochondrial peptide signalling.

Evidence snapshot

Representative findings from MOTS‑c metabolic and performance research.

Model / context	Observation	Notes
High-fat diet rodents Metabolic	MOTS‑c treatment improves insulin sensitivity, glucose tolerance and body-weight gain trajectories, with upregulated AMPK and mitochondrial markers in skeletal muscle.	Used as a model for metabolic syndrome and obesity-linked insulin resistance.
Exercise performance in mice Endurance	MOTS‑c increases running capacity and total work output in young, middle-aged and old mice, independent of baseline body weight effects.	Suggests genuine functional enhancement rather than simple weight-loss driven performance changes.
Myocardial performance Cardiac	Combined with aerobic training in rats, MOTS‑c improves myocardial mechanical efficiency, systolic function and exercise-induced cardiac adaptation markers.	Positions MOTS‑c as a cardiometabolic adaptation modulator, not just skeletal muscle–focused.
Human correlational data Early human	Circulating MOTS‑c levels correlate with fitness and metabolic health indices in some cohorts and rise after certain exercise protocols.	Direct human intervention trials remain limited and exploratory.

Risk frame & unknowns

Caveats in translating MOTS‑c into human protocols.

Important research caveats

Most robust data are from rodent and cell models; human interventional data are still sparse and short-term.
Long-term, high-dose activation of AMPK and exercise pathways could have unanticipated effects on growth, reproduction or stress-adaptation trade-offs.
Interactions with existing exercise routines, caloric deficits and other metabolic drugs or peptides are not systematically mapped.
Use outside strictly controlled research environments risks over-extending mechanistic hype into unvalidated anti-aging or fat-loss protocols.

This dossier summarizes mechanistic, preclinical and emerging human findings on MOTS‑c for scientific and educational purposes only. It does not provide medical advice, treatment guidance or dosing recommendations.